The Role of Interleukins 1 and 6 in Ovarian Cancer
Author Information
Author(s): Woolery Kamisha T., Kruk Patricia A.
Primary Institution: University of South Florida
Hypothesis
Understanding how ovarian epithelial cells interact with their microenvironment can provide insights into ovarian cancer progression and potential therapeutic targets.
Conclusion
Interleukins 1 and 6 significantly impact ovarian cancer progression and may serve as therapeutic targets.
Supporting Evidence
- Ovarian cancer is the leading cause of gynecologic cancer death in women in the US.
- IL-6 is associated with poor prognosis in ovarian cancer.
- IL-1β promotes invasiveness and tumor angiogenesis in ovarian cancer.
- Elevated levels of IL-1 and IL-6 in ascites are linked to ovarian cancer progression.
- IL-1α has tumor suppressor functions that may be beneficial in early disease stages.
Takeaway
This study looks at how two proteins, IL-1 and IL-6, affect ovarian cancer and how they might help doctors treat it better.
Methodology
The paper is based on a broad literature survey of 25 years of research on IL-1 and IL-6 in relation to ovarian cancer.
Limitations
The study primarily reviews existing literature and may not include new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website